Another indication bites the dust! bipolar phase 3 trial flops just like agitation in Alzheimer’s ⌛️⏰. Wonder what spin KM will have for us.... https://endpts.com/antipsychotic-from-lundbeck-otsuka-flops-again-in-phiii-trials-this-time-in-bipolar-patients/
I'm out of here. Good luck to all who decide to stay, but I'm done with neuro, done with the metrics, and done with this company that cannot define success
The idiots that run this company should all be fired! It doesn’t matter I guess. The generics will end burying the brand drugs anyway. Me-too drugs like Rexulti are lucky to sell even 1 script.
Keep pushing ambiguity. If these fucktards weren’t wearing it like a fucking badge maybe someone would have jeot an eye on trials. Buh bye rexalti & Maintena. Both are going nowhere.
The only employees held accountable are the account managers. Employees above us can make mistakes and no one has the power to hold them accountable.
